- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01329601
Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI (ECIF)
Effect of the Stage Specific Cognitive Intervention Program on Functional Cortical Activation in Alzheimer's Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Subject of the proposed project is to offer based on existing theoretical principles and methods stage-related, reproducible, relevant to everyday life group training in German for people with aMCI and slightly severe AD and compared with a - in terms of goal variables - to be less effective prestigious intervention . It is believed that the "active treatment" - in the intervention group, the overall level of functioning can longer be maintained and that positive transfer effects on non-cognitive level - to achieve and cognitive level - here at nationals. In addition, information is expected that the conversion rate of people with dementia and aMCI cut to a further loss of independence in humans can be delayed slightly with severe AD. The project aims to provide data to estimate the effect sizes of intervention can be determined on the basis of group size and duration of ongoing investigations.
Involving functional imaging measures, the intervention study, an adequate platform for the detection of intervention effects on neurobiological basis using fMRI dar. Here, the cerebral blood flow in specific activation as a measure of neuronal and synaptic activity and integrity both in cross-section of a subsample of healthy elderly people studied determined and changes in cerebral activity patterns in people with severe AD, aMCI or slightly in comparison pre-/post interventions. There are detectable much earlier in the pathogenesis of functional changes as structural, using fMRI, the study is to make a significant contribution to prove whether a modular cognitive intervention altered neural and synaptic activity and whether this change is accompanied by an improvement in cognitive performance.
A complete and proven effectiveness of cognitive group training could make a significant contribution that people with MCI and severe AD easily submit their own initiative mental condition, and add itself to sustain the intellectual, emotional and social potential. As a long-term perspective, the results for the optimization of cognitive intervention programs and continue to implement the organizations of the open and contribute stationary the elderly and specialized medical facilities and other medical facilities.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Mecklenburg-Western Pomerania
-
Rostock, Mecklenburg-Western Pomerania, Germany, 18147
- Recruiting
- Department of Psychiatry, University of Rostock
-
Principal Investigator:
- Stefan J. Teipel, Prof. Dr.
-
Contact:
- Stefan J. Teipel, Prof. Dr.
- Phone Number: 9471 0049-381-494
- Email: stefan.teipel@med.uni-rostock.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosis of Mild Cognitive Impairment, Amnestic type (single domain) according to Petersen criteria or a low grade AD according to ICD-10/NINCDS-ADRDA
Exclusion Criteria:
- Major depression
- severe visual and acoustic impairment
- severe physical impairments
- known malignancy
- laboratory elevated inflammatory markers (ESR, CRP, leukocytes)
- stroke
- brain trauma
- epilepsy
- previous participation in a memory training
- patients receiving drug treatment (antidepressants, neuroleptics, anti-dementia, other brain performance enhancing drugs) at least three months prior to study initiation for the duration of the project are at a stable dosage
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Intervention
StaCog intervention to improve cognitive performance and activities of daily living in AD and MCI
|
StaCog intervention to improve cognitive performance and activities of daily living in AD and MCI
Other Names:
|
|
Active Comparator: Booklet-based training
Home based training of episodic memory using paper-pencil exercizes
|
Home based training of episodic memory using paper-pencil exercizes
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
California Verbal Learning Test
Time Frame: Detecting changes between two different time points (baseline and 6 months)
|
Cognitive test for episodic memory
|
Detecting changes between two different time points (baseline and 6 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
functional cortical activity in fMRI
Time Frame: Detecting changes between two different time points (baseline and 6 months)
|
Measure of cortical activation during n-back letter recognition with emotional modulation
|
Detecting changes between two different time points (baseline and 6 months)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stefan J. Teipel, Prof. Dr., Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Rostock
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Int_HRO_1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia of the Alzheimer Type
-
Tianjin Anding HospitalRecruitingBPSD | Amisulpride | Olanzapine | Dementia of the Alzheimer TypeChina
-
Charite University, Berlin, GermanyWithdrawnDementia of Type AlzheimerGermany
-
Douglas Mental Health University InstituteMcGill University; Weston Brain InstituteCompletedMild Cognitive Impairment Due to Alzheimer Disease | Age-related Cognitive Decline | Dementia of the Alzheimer TypeCanada
-
Wanbangde Pharmaceutical Group Co., LTDNot yet recruiting
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompleted
-
Chase Pharmaceuticals Corporation, an affiliate...CompletedDementia of Alzheimer's TypeUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Estonia, Germany, Poland, Portugal, Puerto Rico
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Participants With Dementia of the Alzheimer's TypeUnited States, Canada
-
Otsuka Pharmaceutical Co., Ltd.TerminatedAgitation Associated With Dementia of the Alzheimer's TypeJapan
-
Boehringer IngelheimTerminated
Clinical Trials on StaCog, stage specific cognitive Intervention
-
University Hospital, BordeauxMerck Serono International SA; ARSEP foundationCompletedMultiple Sclerosis | Cognitive RehabilitationFrance
-
Institut Investigacio Sanitaria Pere VirgiliInstitut Pere MataRecruiting
-
Rabin Medical CenterTel Aviv UniversityRecruitingRehabilitation | Hip Fracture | Cognitive InterventionIsrael
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Queen Mary Hospital, Hong Kong; Kowloon... and other collaboratorsCompleted
-
Université de MontréalCentre de Recherche de l'Institut Universitaire en santé Mentale de MontréalCompleted
-
HaEmek Medical Center, IsraelCompleted
-
The University of Hong KongRecruitingNeoplasms | Weight Management | Physical Symptom DistressHong Kong
-
Sport Injury Prevention Research CentreUnknown
-
University Hospital, LimogesCompletedthe Elderly of 75 Years and Older Living at HomeFrance
-
Karolinska InstitutetActive, not recruitingObsessive-Compulsive Disorder | Generalized Anxiety Disorder | Posttraumatic Stress Disorder | Social Anxiety Disorder | Panic DisorderSweden